KIF22 promotes bladder cancer progression by activating the expression of CDCA3

Bladder cancer is a common malignant tumor of the urinary system and is associated with a high morbidity and mortality, due to the difficulty in the accurate diagnosis of patients with early-stage bladder cancer and the lack of effective treatments for patients with advanced bladder cancer. Thus, no...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Kai, Li, Song, Tang, Shuai, Zhang, Minghao, Ma, Zhen, Wang, Qi, Chen, Fangmin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522959/
https://www.ncbi.nlm.nih.gov/pubmed/34633053
http://dx.doi.org/10.3892/ijmm.2021.5044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522959/
https://www.ncbi.nlm.nih.gov/pubmed/34633053
http://dx.doi.org/10.3892/ijmm.2021.5044

Ejemplares similares